Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KeyGene gets US patent for HT screening

The Dutch genomics company, KeyGene (Wageningen), has been awarded a US patent (8,614,073) for high-throughput screening of mutagenised plant populations. The patent protects methods for detecting induced and natural genetic variation in large plant populations that form the cornerstone of KeyGene's KeyPoint MB (mutation breeding) programmes. KeyPoint MB delivers genetic variation in important crop traits such as yield, biotic and abiotic stress resistances, and plant reproduction, the company says. The technology has enabled KeyGene to produce pre-breeding materials for canola, maize, soybeans, wheat and a number of vegetable crops within "timeframes of months" and in an "unrivalled cost-effective" way. Application of KeyPoint MB does not fall under GMO legislation, thereby broadening the application space for genetic improvement of a wide variety of crops. The US patent follows other patents in Australia, Europe, Japan and China (Agrow No 638, p 30).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG000858

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel